AOD-9604 Therapy

AOD-9604 stimulates lipolysis (the breakdown of stored fat) and inhibits lipogenesis (the formation of new fat) by mimicking the way natural growth hormone regulates fat metabolism. It interacts with beta-3 adrenergic receptors on fat cells, triggering the release of stored fatty acids for use as energy. Importantly, AOD-9604 does not compete for the growth hormone receptor and does not increase IGF-1 levels, meaning it does not produce the growth-promoting or blood sugar-elevating effects of growth hormone. This selectivity for fat metabolism without broader hormonal stimulation is what distinguishes it from other GH-related peptides and makes it suitable for patients who specifically want fat reduction support.

AOD-9604 is commonly sought by individuals who are relatively lean but struggle with specific stubborn fat deposits that resist dietary and exercise interventions. Patients who want to avoid the broader hormonal effects of growth hormone therapy but desire its fat-reducing benefits are ideal candidates. It is also popular among those already following structured fitness and nutrition programs who want additional metabolic support to achieve their body composition goals.

AOD-9604 is administered via subcutaneous injection, typically in the abdominal area near the fat deposits being targeted. Most protocols call for daily injections on an empty stomach, often in the morning before eating. Treatment courses typically run 12 to 20 weeks. Some practitioners combine AOD-9604 with intermittent fasting protocols for potentially enhanced effects.